PROCEPT BIOROBOTICS CORP (PRCT) Stock Balance Sheet
NASDAQ:PRCT - Nasdaq - US74276L1052 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 10.96M | N/A | 8.90M | 13.60M | N/A | |||
| Cash Equivalents | 322.76M | 250.61M | 213.00M | 290.70M | 100.10M | |||
| Receivables | 83.50M | 48.38M | 15.30M | 4.50M | 1.50M | |||
| Inventories | 56.17M | 39.76M | 28.50M | 14.00M | 7.50M | |||
| Other Current Assets | 8.45M | 5.21M | 7.00M | 3.40M | 1.10M | |||
| Total Current Assets | 481.84M | 350.57M | 272.60M | 326.20M | 110.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 45.65M | 48.99M | 32.10M | 8.30M | 12.90M | |||
| Intangibles | 932.00K | 1.20M | 1.50M | 1.80M | 2.00M | |||
| Other Non-Current Assets | 5.59M | 3.96M | 3.10M | 800.00K | 800.00K | |||
| Total Non-Current Assets | 52.18M | 54.15M | 36.70M | 10.80M | 15.70M | |||
| TOTAL ASSETS | 534.02M | 404.72M | 309.30M | 337.00M | 126.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 4.60M | |||
| Accrued Expenses | 27.63M | 22.29M | 20.70M | 11.20M | 7.80M | |||
| Accounts Payable | 10.03M | 13.50M | 9.40M | 2.00M | 1.20M | |||
| Other Current Liabilities | 15.47M | 10.14M | 5.20M | 3.00M | 900.00K | |||
| Total Current Liabilities | 53.13M | 45.93M | 35.30M | 16.20M | 14.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 51.47M | 51.34M | 51.20M | 50.00M | 44.40M | |||
| Other Non-Current Liabilities | 27.19M | 26.70M | 25.80M | 3.70M | 6.10M | |||
| Total Non-Current Liabilities | 78.66M | 78.04M | 77.00M | 53.70M | 50.50M | |||
| TOTAL LIABILITIES | 131.80M | 123.97M | 112.30M | 69.90M | 65.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -545.99M | -454.57M | -348.70M | -261.50M | -201.70M | |||
| Additional Paid In Capital | 948.09M | 735.24M | 545.80M | 528.70M | 18.80M | |||
| Common Shares | 600.00 | 500.00 | 0.00 | 0.00 | 243.90M | |||
| Other Shareholders' Equity | -600.00 | -500.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 54.72M | 50.77M | 44.80M | 43.70M | 42.30M | |||
| Tangible Book Value per Share | 7.33 | 5.51 | 4.37 | 6.07 | -4.37 | |||
| Total Shareholders' Equity | 402.22M | 280.75M | 197.10M | 267.10M | 61.00M | |||
| TOTAL LIABILITIES AND EQUITY | 534.02M | 404.72M | 309.30M | 337.00M | 126.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.13 | 0.18 | 0.26 | 0.19 | 0.73 | |||
| Current Ratio | 9.07 | 7.63 | 7.72 | 20.14 | 7.61 | |||
| Return On Assets (ROA) | -17.12% | -26.17% | -28.18% | -17.76% | -42.08% | |||
| Return On Equity (ROE) | -22.73% | -37.72% | -44.22% | -22.41% | -86.92% | |||
All data in USD , ROIC based on taxRate of 0.21